Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00344786 · ClinicalTrials.gov registry record · Phase 1
Phase 1, Dose-Escalation Study of Oral CNF2024(BIIB021) in CLL
A Phase 1 study, sponsored by Biogen.
- Terminated
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT00344786 is a Phase 1 study that was terminated before completion, run by Biogen. The registered enrollment target is 15 participants.
The verdict
NCT00344786, a Phase 1 study, was terminated before completion, sponsored by Biogen.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
CLL dosing escalating study; daily dosing schedule; PK/PD safety
Interventions
- DRUG CNF2024 (BIIB021)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2006-02 |
| Est. Completion | 2008-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00344786
The ClinicalTrials.gov registry entry for NCT00344786 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CNF2024 (BIIB021) is the first listed.
NCT00344786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00344786 about?
NCT00344786 is a clinical study titled "Phase 1, Dose-Escalation Study of Oral CNF2024(BIIB021) in CLL". CLL dosing escalating study; daily dosing schedule; PK/PD safety
What is the current status of trial NCT00344786?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2006-02. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00344786?
The interventions under investigation include: CNF2024 (BIIB021) (DRUG).
Who is sponsoring clinical trial NCT00344786?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.